Your browser doesn't support javascript.
loading
Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Rensing-Ehl, Anne; Völkl, Simon; Speckmann, Carsten; Lorenz, Myriam Ricarda; Ritter, Julia; Janda, Ales; Abinun, Mario; Pircher, Hanspeter; Bengsch, Bertram; Thimme, Robert; Fuchs, Ilka; Ammann, Sandra; Allgäuer, Andrea; Kentouche, Karim; Cant, Andrew; Hambleton, Sophie; Bettoni da Cunha, Claudia; Huetker, Sebastian; Kühnle, Ingrid; Pekrun, Arnulf; Seidel, Markus G; Hummel, Michael; Mackensen, Andreas; Schwarz, Klaus; Ehl, Stephan.
Afiliação
  • Rensing-Ehl A; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;
  • Völkl S; Department of Internal Medicine 5, Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany;
  • Speckmann C; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Center for Paediatrics and Adolescent Medicine, University Medical Center, University of Freiburg, Freiburg, Germany;
  • Lorenz MR; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany;
  • Ritter J; Institute of Pathology, Charité - University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany;
  • Janda A; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Center for Paediatrics and Adolescent Medicine, University Medical Center, University of Freiburg, Freiburg, Germany;
  • Abinun M; Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom; Institute of Cellular Immunology, Newcastle University, Newcastle upon Tyne, United Kingdom;
  • Pircher H; Institute of Immunology, Department of Medicine Microbiology and Hygiene, and.
  • Bengsch B; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Department of Internal Medicine II, University Medical Center Freiburg, Freiburg, Germany;
  • Thimme R; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Department of Internal Medicine II, University Medical Center Freiburg, Freiburg, Germany;
  • Fuchs I; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;
  • Ammann S; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany;
  • Allgäuer A; Department of Internal Medicine 5, Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany;
  • Kentouche K; Department of Paediatrics, Jena University Hospital, Jena, Germany;
  • Cant A; Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom; Institute of Cellular Immunology, Newcastle University, Newcastle upon Tyne, United Kingdom;
  • Hambleton S; Department of Paediatric Immunology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom; Institute of Cellular Immunology, Newcastle University, Newcastle upon Tyne, United Kingdom;
  • Bettoni da Cunha C; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hanover Hannover, Germany;
  • Huetker S; Division of Pediatric Haematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Göttingen, Göttingen, Germany;
  • Kühnle I; Division of Pediatric Haematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Göttingen, Göttingen, Germany;
  • Pekrun A; Department of Paediatric Haematology/Oncology, University Medical Center Bremen, Bremen, Germany.
  • Seidel MG; Paediatric Haematology-Oncology, Medical University of Graz, Graz, Austria; and.
  • Hummel M; Institute of Pathology, Charité - University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany;
  • Mackensen A; Department of Internal Medicine 5, Haematology and Oncology, University Hospital Erlangen, Erlangen, Germany;
  • Schwarz K; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Institute for Transfusion Medicine, University of Ulm, Ulm, Germany; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service, Ulm, Germany
  • Ehl S; Center for Chronic Immunodeficiency, University Medical Center Freiburg and University of Freiburg, Freiburg, Germany; Center for Paediatrics and Adolescent Medicine, University Medical Center, University of Freiburg, Freiburg, Germany;
Blood ; 124(6): 851-60, 2014 Aug 07.
Article em En | MEDLINE | ID: mdl-24894771
ABSTRACT
Accumulation of CD3(+) T-cell receptor (TCR)αß(+)CD4(-)CD8(-) double-negative T cells (DNT) is a hallmark of autoimmune lymphoproliferative syndrome (ALPS). DNT origin and differentiation pathways remain controversial. Here we show that human ALPS DNT have features of terminally differentiated effector memory T cells reexpressing CD45RA(+) (TEMRA), but are CD27(+)CD28(+)KLRG1(-) and do not express the transcription factor T-bet. This unique phenotype was also detected among CD4(+) or CD8(+) ALPS TEMRA cells. T-cell receptor ß deep sequencing revealed a significant fraction of shared CDR3 sequences between ALPS DNT and both CD4(+) and CD8(+)TEMRA cells. Moreover, in ALPS patients with a germ line FAS mutation and somatic loss of heterozygosity, in whom biallelic mutant cells can be tracked by absent Fas expression, Fas-negative T cells accumulated not only among DNT, but also among CD4(+) and CD8(+)TEMRA cells. These data indicate that in human Fas deficiency DNT cannot only derive from CD8(+), but also from CD4(+) T cells. Furthermore, defective Fas signaling leads to aberrant transcriptional programs and differentiation of subsets of CD4(+) and CD8(+) T cells. Accumulation of these cells before their double-negative state appears to be an important early event in the pathogenesis of lymphoproliferation in ALPS patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Subpopulações de Linfócitos T / Linfócitos T CD8-Positivos / Receptor fas / Síndrome Linfoproliferativa Autoimune Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Blood Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Subpopulações de Linfócitos T / Linfócitos T CD8-Positivos / Receptor fas / Síndrome Linfoproliferativa Autoimune Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans Idioma: En Revista: Blood Ano de publicação: 2014 Tipo de documento: Article